ECM Therapeutics, Inc. today announced early clinical results suggesting its extracellular matrix (ECM) hydrogel, ECMT-100, could meaningfully improve treatment for patients with anorectal fistulas, ...
PITTSBURGH--(BUSINESS WIRE)--ECM Therapeutics, a clinical stage regenerative medicine company pioneering the development of Extracellular Matrix-based therapeutics for the treatment of unmet medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results